Companies / Akebia Therapeutics, Inc.

Akebia Therapeutics, Inc.

Nasdaq: AKBACIK 1517022CAMBRIDGE, MA

Financials · FY2025

Revenue$236.20M
Net income$-5.34M
Total debt$49.56M
Cash$155.55M
Diluted EPS$-0.02
Shares outstanding277.1M

Ownership

277.1M shares outstanding · as of Jul 31, 2026
2.2%Insiders
Ownership
Insiders2.21%6,128,610
10%+ / strategic11.88%32,907,380
Institutions31.07%86,088,993
Public float54.85%151,981,262

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Butler John P.CEOCEO and President · Director
1.22%3,367,064
Burke Steven KeithSVP, Chief Medical Officer
0.34%948,432
Ostrowski ErikSVP, CFO, CBO & Treasurer
0.24%672,635
Rucci Carolyn M.FormerSVP, Chief Legal Officer
0.21%588,378
Grund NicholasChief Commercial Officer
0.20%561,750
Malabre Richard CFormerSVP, Chief Accounting Officer
0.11%299,390
Adams AdrianDirector
0.09%236,200
Rogers Michael WDirector
0.07%197,429
Zumwalt Leanne MDirector
0.05%145,100

Institutional holders 173

View all →
HolderValue% of shares
Vanguard Group Inc$25.79M5.78%
BlackRock, Inc.$22.78M7.21%
Geode Capital Management, LLC$8.97M2.33%
The Goldman Sachs Group, Inc.$7.58M1.70%
Citadel Advisors LLC$7.51M1.68%
State Street Corporation$6.15M1.95%
Qube Research & Technologies Ltd$4.82M1.08%
Citigroup Inc$3.92M0.88%
Northern Trust Corp$3.72M0.83%
Bank of America Corp /De$3.63M0.81%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 2, 2026Butler John P.
CEO
GrantCommon Stock$247.1K+175K
+5.47%
3,381,483
1.22% of shares
low
Feb 2, 2026Butler John P.
CEO
SellCommon Stock$159.7K-115K
-3.46%
3,206,233
1.16% of shares
medium
Feb 2, 2026Butler John P.
CEO
SellCommon Stock$133.5K-96K
-2.81%
3,321,124
1.20% of shares
medium
Feb 2, 2026Butler John P.
CEO
SellCommon Stock$116.3K-84K
-2.47%
3,297,794
1.19% of shares
medium
Mar 4, 2026Butler John P.
CEO
BuyCommon Stock$86.6K+69K
+2.10%
3,367,064
1.22% of shares
medium
Feb 2, 2026Grund Nicholas
Executive
SellCommon Stock$74.5K-54K
-8.29%
592,994
0.21% of shares
low
Feb 2, 2026Butler John P.
CEO
SellCommon Stock$64.9K-47K
-1.35%
3,417,189
1.23% of shares
low
Feb 2, 2026Malabre Richard C
Executive
SellCommon Stock$50.2K-36K
-10.36%
312,772
0.11% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
BlackRock, Inc.Passive13G/A—19,219,819—
State Street CorporationPassive13G—13,687,561—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
AKBA——00972D105—